The best thing about the stock market is that you can make money in�either direction. Historically, stock indexes have tended to trend up over the long term. But when you look at individual stocks, you'll find plenty that lose money over the long haul. According to hedge fund institution Blackstar Funds, even with dividends�included, between 1983 and 2006, 64% of stocks underperformed the Russell 3000, a broad-scope market index.
A large influx of short-sellers shouldn't be a condemning factor to any company, but it could be a red flag from traders that something may not be as cut-and-dried as it appears. Let's look at three companies that have seen a rapid increase in the number of shares sold short and see whether traders are blowing smoke or if their worry has some merit.
Company
Short Increase March 15 to March 29
Short Shares as a % of Float
Diana Shipping (NYSE: DSX )
Top 10 Supermarket Stocks To Own For 2016: Experian PLC (EXPGY)
Experian plc, incorporated on June 30, 2006, is a provider of global information services. The Company provides data and analytical tools to organizations in North America, Latin America, the United Kingdom and Ireland, Europe, the Middle East and Africa (EMEA) and Asia Pacific. Clients use these to manage credit risk, prevent fraud, target marketing offers and automate decision-making. Activities in the regions in which Experian operates are grouped into four global business lines: Credit Services, Decision Analytics, Marketing Services and Interactive. Experian provides data and analytical tools to organizations in North America, Latin America, United Kingdom and Ireland, EMEA and Asia Pacific. In November 2013, the Company acquired Passport Health Communications, Inc.
Credit Services
Experian helps organizations to manage credit risk, prevent fraud, target marketing offers and automate decision making. The Company also provides credit monitoring and identity protection services to millions of consumers via the Internet. At the core of Credit Services are the databases that Experian builds and manages, that hold the credit application and repayment histories of consumers and businesses. Globally, Experian holds credit payment data on consumers and million businesses. In total, Experian operates approximately 20 consumer credit bureaux and approximately15 business credit bureau worldwide. Experian�� automotive business supplies vehicle history reports in the United States, the United Kingdom, Ireland and Italy. Reports typically include data on title, registration, history and accidents, manufacturer recall and repair records. The information is sold to automotive dealers, auction houses, automotive companies and direct-to-consumer. Clients principally include organizations that are extending or offering credit, such as financial services, telecommunications, utilities, insurance companies, hospitals and automotive dealers.
The Company competes with Dun & Bra! dstreet.
Decision Analytics
Solutions developed by Experian include application processing, customer management, fraud solutions and collections software and systems. Decision Analytics products are also used in the detection and prevention of fraud. Clients include financial services, telecommunications, utilities, retailers, insurance, automotive and the public sector.
It competes with Fair Isaac and SAS.
Marketing Services
Marketing Services provides data and segmentation tools to the organizations. Experian provides Marketing Services in some 30 countries. Marketing Services maintains databases of marketing information on consumers. Consumer profiles include data from many sources, including market surveys, postal addresses, electoral registers, Internet service providers and magazine subscription data. Globally, Experian holds demographic data on more than 700 million individuals in approximate 270 million households and online behavior data on Internet users across Websites. Experian has a Marketing Services presence worldwide, including Australia, Brazil, China, France, Germany, Japan, the United Kingdom and the United States. Clients include financial services, retail, media, automotive and the public sector.
The Company competes with Acxiom, Epsilon, WPP, Omnicom, ExactTarget, Responsys, Neolane and eDialog.
Interactive
The Company�� Consumer Direct business provides credit monitoring and other information services directly to millions of consumers via the Internet. It enables consumers to monitor the accuracy of their credit report, to check their credit score and to protect against identity theft. Experian provides consumers with online access to their credit history. In the United States, CreditReport.com and freecreditscore.com, and in the United Kingdom, CreditExpert.co.uk, allow consumers to see the same information available to lenders. Experian�� identity protection services in ! the Unite! d States and the United Kingdom, ProtectMyID.com and ProtectMyID.co.uk, provide identity theft detection, protection and fraud resolution to consumers. In the United States, Safetyweb.com helps parents monitor their children�� online activity and its DataPatrol product provides realtime Web and social network monitoring to help prevent identity fraud before it happens.
The Company competes with Equifax, CallCredit, TransUnion and Fair Isaac.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
Karen Roach/Shutterstock When singles are looking for love, they typically don't start by checking out a potential mate's credit score. But maybe they should. A recent survey of 1,010 married people by Experian (EXPGY) Consumer Services division found that 95 percent of those polled rate financial responsibility as an important attribute in a spouse. Compare that to physical attractiveness -- often the first criterion we use to judge potential mates -- which was deemed an important trait for compatibility by just 86 percent. (Personal compatibility led the list at 98 percent.) Financial communication can be an important barometer of how successful a relationship will be, although women place more of a premium on it than men. Among those surveyed, 73 percent of women and 60 percent of men said that being open about personal finances and credit makes a person more attractive as a spouse. On the flip side, 59 percent of women and 44 percent of men say that a partner who avoids talking about those things is less attractive as a spouse. What's Your Number? "Financial debt and a person's credit score are so important to disclose before you tie the proverbial knot," says Les Parrott, co-author with his wife, Leslie, of "Making Happy" and "The Good Fight." "We can tell you about lots of disastrous money surprises when a person isn't up front about this." It's important to discuss all aspects of your individual and shared financial situations regularly with your significant other, but because your credit score will impact your ability to make major purchases like a home or a car, it's especially important to determine whether a low credit score tied to one or both of you may affect your long-term goals, says Suzanna de Baca, vice president of wealth strategies at Ameriprise Financial (AMP). "An important step toward having a successful relationship is being willing to share your feelings about money with your partner. This includes being honest about past and p
- [By WWW.DAILYFINANCE.COM]
Jupiterimages.com When it comes to understanding your credit, it can feel as complicated as trying to solve a Rubik's cube. Frustrated by this confusion, many consumers neglect their credit, which can have a devastating impact on their financial futures. A Consumer Action study recently revealed that 27 percent of Americans have never checked their credit report. That's alarming, because it's estimated that a large numbers of consumers have errors on their credit reports that could damage their credit. I found this out several years ago when I found an error -- a canceled account that was being reported as delinquent -- hurting my credit. In my research, I have identified three sneaky things that are hurting other people's credit, too. Surprisingly, they could be fixed in 15 minutes or less. First, you need to get your credit report, and you should go to AnnualCreditReport.com. From this site, you can request your free credit report once a year from the three major credit reporting agencies -- (Equifax (EFX), Experian (EXPGY) and TransUnion). You can also access your credit score there, but you'll have to pay a small fee. To get a free credit score, you can go to Credit.com or Creditkarma.com. Keep in mind that these two as well as a lot of other free sites offer a consumer education score, which isn't your actual FICO (FICO) score. This confused even me when I sought to find my real credit score. Your FICO score changes daily, so getting your credit scores from these free sites will give you a good gauge of approximately what your credit score is. 1. Wrong Information The wrong personal information on your credit report could hurt your credit. This could be things like your name, your home address, where you've worked in the past or even your Social Security number. How does a wrong address hurt your credit? Your information may be mixed up with someone else's, especially if you have a common name, or are a "Jr." or "Sr." Or it could indicate identity th
Top 5 Companies To Invest In Right Now: Sibanye Gold Ltd (SBGL)
Sibanye Gold Limited (Sibanye Gold), formerly GFI Mining South Africa (Pty) Limited, incorporated on December 12, 2002, is a producer of gold in South Africa. Sibanye Gold is primarily engaged in underground and surface gold mining and related activities, including extraction, and processing. Sibanye Gold�� operations are located in South Africa. Its principal mining operations include Kloof-Driefontein Complex (KDC) and Beatrix. Exploration activities are focused on the extension of existing ore bodies and identification of new ore bodies at existing sites. As of January 10, 2013, Sibanye Gold mined only gold, with silver as a by-product.
KDC Operation
The KDC mine is located in the Gauteng Province of South Africa in the Far West Rand mining district, some 60 kilometers southwest of Johannesburg. KDC consists of the Driefontein and Kloof mines. As of January 10, 2013, KDC is consisted of 13 producing shaft systems that mine different contributions from pillars and open ground and five gold plants of which two process mainly underground ore and three process mainly surface material. Driefontein is situated some 70 kilometers west of Johannesburg. Kloof is situated in the Magisterial District of Westonaria, some 60 kilometers west of Johannesburg.
Beatrix Operation
The Beatrix operation is located in the Free State Province of South Africa, some 240 kilometers southwest of Johannesburg, near Welkom and Virginia, and consists of the Beatrix mine. Beatrix operates under mining rights covering a total area of approximately 16 800 hectares. As of January 10, 2013, Beatrix had four shaft systems, with five ventilation shafts to provide additional up-cast and down-cast ventilation capacity and is serviced by two metallurgical plants. It is a shallow to intermediate-depth mining operation, at depths between 700 meters and 2 200 meters below surface. The mine has a refrigeration and cooling infrastructure in both its North and West Sections. Beatrix is man! aged as three operational sections: the North Section (consists of Shaft No. 3), the South Section (consists of Shaft No. 2 and Shaft No. 1) and the West Section (consists of Shaft No. 4).
Advisors' Opinion:- [By Lisa Levin]
Gold: This industry rose 0.65% by 10:25 am ET. The top performer in this industry was Sibanye Gold (NYSE: SBGL), which gained 4.9%. Gold futures fell 0.17% to trade at $1,216.70 an ounce.
- [By Lisa Levin]
Gold: This industry jumped 1.20% by 11:40 am. The top performer in this industry was Sibanye Gold (NYSE: SBGL), which rose 3.2%. Gold futures gained 0.44% to trade at $1,281.00 an ounce.
Top 5 Companies To Invest In Right Now: Exelixis Inc.(EXEL)
Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer. It focuses on developing Cabozantinib, an inhibitor of tumor growth, metastasis, and angiogenesis that target MET, VEGFR2, and RET, which are key kinases involved in the development and progression of various cancers. The cabozantinib is in Phase III clinical trial for the treatment for medullary thyroid cancer. The company also engages in various clinical programs for cabozantinib focused on the treatment of metastatic castration-resistant prostate cancer, ovarian cancer, breast cancer, renal cell carcinoma, non-small cell lung cancer, hepatocellular cancer, and melanoma. In addition, Exelixis, Inc. involves in developing a portfolio of other novel compounds to address serious unmet medical needs through collaborations with various pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, sanofi-aventis, Genentech, Inc., Boehringer Ingelheim Gm bH, and GlaxoSmithKline and Daiichi Sankyo Company Limited. Its products under development through collaborations include XL475, XL281, XL139, and XL413 inhibitors; ROR antagonists; therapies targeted against LXR, a nuclear hormone receptor implicated in various cardiovascular and metabolic disorders; XL147, XL765, and isoform-selective PI3K inhibitors; XL518, a small-molecule inhibitor of MEK; sphingosine-1-phosphate type 1 receptor; XL880 inhibitor; and therapies targeted against the mineralocorticoid receptor, a nuclear hormone receptor implicated in various cardiovascular and metabolic diseases. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By Selena Maranjian]
Companies that stand a good chance of surging in coming years are also good Roth candidates. Exelixis (NASDAQ: EXEL ) , for example, is a smallish biotech company tackling various cancers. It even has an approved thyroid cancer drug on the market, and the formula may end up approved to treat other conditions, as well. The downside, though, is that the drug is expensive, and the segment of thyroid-cancer patients who might take it is very small.
- [By Eddie Staley]
Exelixis (NASDAQ: EXEL) shares shot up 21.18 percent to $4.03 after the company announced positive phase 3 data for coBRIM.
Shares of Kandi Technolgies Group (NASDAQ: KNDI) got a boost, shooting up 20.24 percent to $17.70 on report of a 238% rise in EV sales.
- [By Sean Williams]
Where investment dollars are headed
Caprelsa: AstraZeneca's (NYSE: AZN ) Caprelsa was approved to treat unresectable, locally advanced, or metastatic medullary thyroid cancer in April 2011. In trials, AstraZeneca's pill increased progression-free survival over the placebo and delivered an overall response rate of 44%, compared with just 1% for the placebo -- although it should be noted that all responses were partial. However, Caprelsa also comes with a laundry list of side effects that range from something as simple as rash, nausea, and hypertension, to having resulted in death from respiratory arrest and cardiac failure with arrhythmia.� Cometriq: Exelixis' (NASDAQ: EXEL ) Cometriq was approved last November to treat progressive metastatic medullary thyroid cancer. The capsules work by inhibiting multiple tyrosine kinases, which are crucial to blood vessel growth in solid and metastasizing tumors. In late-stage trials, patients receiving Cometriq demonstrated an astounding 11.2 months of progression-free survival compared with just four months for the placebo. Further, the objective response rate was 27% in the Cometriq arm and a goose egg for the placebo arm. Similar to AstraZeneca's Caprelsa, severe adverse reactions tended to increase for Cometriq users relative to the placebo.
Thyroid cancer is treated in nearly every case with a full or partial thyroid removal since the majority of thyroid cancers aren't aggressive. However, in those rare cases where surgery isn't an option or the disease has metastasized to other parts of the body, there are two drugs approved by the Food and Drug Administration to choose from.Just as we've witnessed with every previous cancer in this series, not every drug trial proves successful. Pfizer's (NYSE: PFE ) Sutent, for instance, is a very successful treatment for kidney cancer, gastrointestinal stromal tumors, and pancreatic endocrine tumors, but it didn't fare as wel
Top 5 Companies To Invest In Right Now: Sunoco Logistics Partners LP (SXL)
Sunoco Logistics Partners L.P. engages in the transport, terminalling, and storage of refined products and crude oil, as well as the purchase and sale of crude oil in the United States. Its Refined Products Pipeline System segment owns and operates approximately 2,200 miles of refined product pipelines that transport gasoline, heating oil, diesel and jet fuel, and liquefied petroleum gas (LPG). This segment also includes approximately 100-mile refined products Harbor pipeline, and 50 miles of inter refinery pipelines; and various joint venture interests in refined product pipeline companies. The company?s Terminal Facilities segment consists of 42 refined product terminals with an aggregate storage capacity of 7.2 million barrels, primarily serving the Refined Products Pipeline System; the Nederland Terminal, a 20.2 million barrel marine crude oil terminal on the Texas Gulf Coast; a 2.0 million barrel refined products terminal serving Sunoco?s Marcus Hook refinery near Phi ladelphia, Pennsylvania; 1 inland and 2 marine crude oil terminals with a combined capacity of 3.4 million barrels, and related pipelines that serve Sunoco?s Philadelphia refinery; and a 1.0 million barrel LPG terminal near Detroit, Michigan. Its Crude Oil Pipeline System segment gathers, purchases, sells, and transports crude oil principally in Oklahoma and Texas. This segment consists of approximately 4,900 miles of crude oil trunk pipelines; approximately 500 miles of crude oil gathering lines; approximately 110 crude oil transport trucks; and approximately 100 crude oil truck unloading facilities. This segment also holds a 91% interest in the Mid-Valley Pipeline Company that owns approximately 1,000 miles of crude oil pipelines; a 60.3% interest in West Texas Gulf Pipe Line Company, which includes approximately 600 miles of crude oil pipe; and a 37.0 percent undivided interest in the 100-mile Mesa Pipe Line system. The company was founded in 2001 and is based in Philadel phia, Pennsylvania.
Advisors' Opinion:- [By Aaron Levitt]
While its former parent Sunoco no longer exists as a standalone company nor as a refiner, Sunoco Logistics Partners (SXL) continues to churn out steady and rising distributions for its shareholders.
- [By Matt DiLallo]
The potential bidders
There are a lot of names being thrown around as potential purchasers of these assets, including Marathon Petroleum (NYSE: MPC ) , Sunoco Logistics (NYSE: SXL ) , and Buckeye Partners (NYSE: BPL ) . Both Sunoco and Buckeye are MLPs, which is where I personally think these assets are best suited. Let's take a closer look at each company to see which one makes the most strategic sense. - [By Dividends4Life]
Sunoco Logistics Partners (SXL) is a master limited partnership (MLP) that was formed by Sunoco Inc. to acquire, own and operate a group of refined product and crude oil pipelines and terminal facilities.
Yield: 3.6% | Years of Dividend Growth: 11
No comments:
Post a Comment